X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4364) 4364
Newsletter (25) 25
Magazine Article (20) 20
Book Chapter (15) 15
Conference Proceeding (5) 5
Book / eBook (2) 2
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3618) 3618
ethanolamines - therapeutic use (2836) 2836
male (2420) 2420
female (2273) 2273
science & technology (2222) 2222
life sciences & biomedicine (2100) 2100
adult (1640) 1640
middle aged (1599) 1599
aged (987) 987
animals (982) 982
ethanolamines - administration & dosage (979) 979
formoterol fumarate (837) 837
asthma - drug therapy (808) 808
drug combinations (799) 799
ethanolamines - pharmacology (768) 768
treatment outcome (666) 666
adolescent (643) 643
pharmacology & pharmacy (596) 596
double-blind method (594) 594
hypertension - drug therapy (578) 578
bronchodilator agents - therapeutic use (562) 562
drug therapy, combination (533) 533
child (517) 517
ethanolamines - adverse effects (516) 516
fluorenes - therapeutic use (483) 483
abridged index medicus (475) 475
antimalarials - therapeutic use (471) 471
artemisinins - therapeutic use (459) 459
time factors (444) 444
blood pressure - drug effects (440) 440
clinical trials as topic (408) 408
nebivolol (406) 406
malaria (397) 397
administration, inhalation (390) 390
respiratory system (380) 380
labetalol - therapeutic use (378) 378
ethanolamines (376) 376
adrenergic beta-agonists - therapeutic use (375) 375
bronchodilator agents - administration & dosage (374) 374
child, preschool (371) 371
dose-response relationship, drug (370) 370
malaria, falciparum - drug therapy (370) 370
asthma (365) 365
drug therapy (360) 360
research (356) 356
albuterol - therapeutic use (353) 353
benzopyrans - therapeutic use (347) 347
heart rate - drug effects (328) 328
formoterol (309) 309
fenoterol - therapeutic use (308) 308
rats (307) 307
infectious diseases (284) 284
adrenergic beta-antagonists - therapeutic use (283) 283
infant (263) 263
tropical medicine (258) 258
young adult (257) 257
cardiovascular system & cardiology (256) 256
budesonide - therapeutic use (254) 254
analysis (252) 252
care and treatment (249) 249
asthma - physiopathology (248) 248
parasitic diseases (245) 245
general & internal medicine (236) 236
research article (232) 232
albuterol - analogs & derivatives (228) 228
pulmonary disease, chronic obstructive - drug therapy (226) 226
mice (220) 220
forced expiratory volume (216) 216
parasitology (216) 216
pregnancy (212) 212
budesonide - administration & dosage (203) 203
health aspects (199) 199
cardiac & cardiovascular systems (198) 198
aged, 80 and over (193) 193
fluorenes - administration & dosage (190) 190
antihypertensive agents - therapeutic use (189) 189
artemisinins - administration & dosage (184) 184
administration, oral (181) 181
antimalarials - administration & dosage (179) 179
salmeterol xinafoate (179) 179
cross-over studies (178) 178
medicine, general & internal (177) 177
plasmodium falciparum (176) 176
plasmodium falciparum - drug effects (174) 174
malaria - drug therapy (173) 173
ethanolamines - pharmacokinetics (171) 171
hypertension (171) 171
hemodynamics - drug effects (168) 168
hypertension - physiopathology (168) 168
dosage and administration (167) 167
aerosols (166) 166
adrenergic beta-agonists - administration & dosage (165) 165
bronchodilator agents - adverse effects (161) 161
albuterol - administration & dosage (159) 159
drug evaluation (158) 158
randomized controlled trials as topic (156) 156
drug administration schedule (155) 155
medicine (146) 146
nebulizers and vaporizers (144) 144
antimalarials (142) 142
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3826) 3826
German (233) 233
Italian (91) 91
French (78) 78
Russian (76) 76
Spanish (45) 45
Japanese (37) 37
Polish (28) 28
Portuguese (24) 24
Ukrainian (19) 19
Czech (12) 12
Bulgarian (8) 8
Dutch (8) 8
Turkish (8) 8
Chinese (7) 7
Romanian (7) 7
Norwegian (5) 5
Croatian (4) 4
Hungarian (4) 4
Danish (3) 3
Serbian (3) 3
Slovak (3) 3
Afrikaans (1) 1
Finnish (1) 1
Hebrew (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet (British edition), ISSN 0140-6736, 2010, Volume 376, Issue 9743, pp. 814 - 825
Summary Children who are referred to specialist care with asthma that does not respond to treatment (problematic severe asthma) are a heterogeneous group, with... 
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Bronchodilator Agents - therapeutic use | Allergens - adverse effects | Spirometry | Azathioprine - therapeutic use | Formoterol Fumarate | Off-Label Use | Terbutaline - therapeutic use | Bronchodilator Agents - administration & dosage | Anti-Asthmatic Agents - therapeutic use | Drug Resistance, Multiple | Humans | Bronchial Provocation Tests | Immunoglobulin E | Tomography, X-Ray Computed | Methotrexate - therapeutic use | Adrenal Cortex Hormones - therapeutic use | Asthma - immunology | Asthma - etiology | Drug Therapy, Combination | Child | Asthma - diagnosis | Severity of Illness Index | Asthma - physiopathology | Comorbidity | Risk Factors | Administration, Inhalation | Treatment Outcome | Clinical Trials as Topic | Asthma - drug therapy | Cyclosporine - therapeutic use | Interdisciplinary Communication | Budesonide, Formoterol Fumarate Drug Combination | House Calls | Tobacco Smoke Pollution - adverse effects | Budesonide - therapeutic use | Ethanolamines - therapeutic use | Anti-Asthmatic Agents - administration & dosage | Drug Combinations | Eosinophils | Monoclonal antibodies | Care and treatment | Diagnosis | Research | Asthma in children | Health aspects | Biomarkers | Medical research | Nitric oxide | Asthma | Index Medicus | Abridged Index Medicus
Journal Article
Toxicology and applied pharmacology, ISSN 0041-008X, 12/2013, Volume 273, Issue 3, pp. 442 - 455
Although reactive oxygen species (ROS) such as superoxide, hydrogen peroxide and hydroxyl radical are generated as the natural byproduct of normal oxygen... 
Oxidative stress | Toxicology | Pharmacology | Disease | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Science & Technology | Diabetes Mellitus - pathology | Vascular Diseases - prevention & control | Benzopyrans - therapeutic use | Reactive Oxygen Species - metabolism | Vascular Diseases - pathology | Stilbenes - therapeutic use | Humans | Oxidative Stress - physiology | Neurodegenerative Diseases - prevention & control | Neoplasms - prevention & control | Propanolamines - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Inflammatory Bowel Diseases - pathology | Disease Models, Animal | Nebivolol | Inflammatory Bowel Diseases - prevention & control | Neurodegenerative Diseases - pathology | Osteoporosis - prevention & control | Hydrogen Peroxide - metabolism | Antioxidants - therapeutic use | Diabetes Mellitus - prevention & control | Animals | Osteoporosis - pathology | Ethanolamines - therapeutic use | Carbazoles - therapeutic use | Oxidative Stress - drug effects | Neoplasms - pathology | Angiotensin Receptor Antagonists - therapeutic use | Antioxidants | Chemotherapy | Hydrogen peroxide | Enzyme inhibitors | Resveratrol | Polyols | Cancer | Index Medicus | OXIDATION | APOPTOSIS | ANTIOXIDANTS | ENZYME INHIBITORS | MITOCHONDRIA | CELL PROLIFERATION | 60 APPLIED LIFE SCIENCES | ANGIOTENSIN | STRESSES | OXYGEN | HYDROXYL RADICALS | CARCINOGENESIS | DISEASES | NECROSIS | METABOLISM | HYDROGEN PEROXIDE | INFLAMMATION
Journal Article
British journal of pharmacology, ISSN 0007-1188, 06/2013, Volume 169, Issue 4, pp. 772 - 783
N-3 long chain polyunsaturated fatty acids (n-3 LC PUFAs), in particular a-linolenic acid (18:3n-3), eicosapentaenoic acid (EPA; 20:5n-3) and docosahexaenoic... 
in-vivo | n-3 | acylethanolamines | cannabinoid-receptor | cardiovascular-disease | amide hydrolase | rat-brain | cancer cell-lines | anandamide | arachidonoyl-serotonin | PUFA, DHA, EPA | endocannabinoid system | n‐3 | fish oil | Endocannabinoids - metabolism | Ethanolamine - therapeutic use | Neuroprotective Agents - therapeutic use | Cannabinoid Receptor Agonists - metabolism | Polyunsaturated Alkamides - chemistry | Eicosapentaenoic Acid - analogs & derivatives | Humans | Fatty Acids, Omega-3 - chemistry | Polyunsaturated Alkamides - therapeutic use | alpha-Linolenic Acid - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - chemistry | Cannabinoid Receptor Agonists - chemistry | Neuroprotective Agents - metabolism | Drug Delivery Systems | Receptors, Cannabinoid - metabolism | Ethanolamine - chemistry | Cannabinoid Receptor Agonists - therapeutic use | Fishes | Anti-Inflammatory Agents, Non-Steroidal - metabolism | Dopamine - metabolism | Endocannabinoids - therapeutic use | Receptors, Cannabinoid - chemistry | Acylation | Docosahexaenoic Acids - therapeutic use | Dopamine - therapeutic use | Fatty Acids, Omega-3 - metabolism | Neuroprotective Agents - chemistry | alpha-Linolenic Acid - analogs & derivatives | Ethanolamine - metabolism | Eicosapentaenoic Acid - metabolism | Polyunsaturated Alkamides - metabolism | Docosahexaenoic Acids - analogs & derivatives | Animals | Dopamine - analogs & derivatives | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | alpha-Linolenic Acid - metabolism | Fatty Acids, Omega-3 - therapeutic use | Eicosapentaenoic Acid - therapeutic use | Seafood - analysis | Dietary Supplements | Fish Oils - chemistry | Endocannabinoids - chemistry | Docosahexaenoic Acids - metabolism | Ethanolamines | Omega-3 fatty acids | Linolenic acids | Fatty acids | Dopamine | Index Medicus | Cannabinoids 2012, Part Two | Themed Section
Journal Article
The New England journal of medicine, ISSN 0028-4793, 11/2012, Volume 367, Issue 22, pp. 2110 - 2118
.... Prophylaxis with trimethoprim–sulfamethoxazole and insecticide-treated bed nets reduce the incidence of malaria among HIV-infected children, but protection is incomplete, and even with the use of these protective strategies... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Artemisinins - pharmacokinetics | Humans | Fluorenes - therapeutic use | Child, Preschool | Infant | Male | Secondary Prevention | Incidence | Ethanolamines - pharmacokinetics | Drug Interactions | Malaria - epidemiology | Ritonavir - therapeutic use | Female | Reverse Transcriptase Inhibitors - therapeutic use | Drug Therapy, Combination | Fluorenes - pharmacokinetics | Anti-Retroviral Agents - therapeutic use | Antimalarials - pharmacokinetics | Kaplan-Meier Estimate | Antimalarials - therapeutic use | HIV Protease Inhibitors - therapeutic use | Malaria - prevention & control | Artemisinins - therapeutic use | Ethanolamines - therapeutic use | HIV Infections - drug therapy | Lopinavir - therapeutic use | Uganda | Malaria - drug therapy | Drug Combinations | Malaria | Patient outcomes | HIV infection in children | Research | Risk factors | Prevention | Complications and side effects | Highly active antiretroviral therapy | Reverse transcriptase inhibitors | Dosage and administration | Comparative analysis | Drug therapy | Health aspects | Antiretroviral drugs | Alanine | Ritonavir | Lopinavir | Insecticides | Proteinase inhibitors | Pruritus | Antiretroviral therapy | Antiretroviral agents | Human immunodeficiency virus--HIV | Alanine transaminase | Artemether | Children | Index Medicus | Abridged Index Medicus
Journal Article
Indian Journal of Medical Research, ISSN 0971-5916, 11/2017, Volume 146, Issue 5, pp. 622 - 628
Background & objectives: The in vitro assays for susceptibility of Plasmodium falciparum to antimalarial drugs are important tools for monitoring drug... 
Antimalarials | Plasmodium falciparum | Field isolates | In vitro culture | Antibiotics | Mizoram | Immunology | Life Sciences & Biomedicine | Medicine, General & Internal | General & Internal Medicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Malaria, Falciparum - drug therapy | Atovaquone - therapeutic use | Doxycycline - therapeutic use | Humans | Fluorenes - therapeutic use | India - epidemiology | Chloroquine - therapeutic use | Antimalarials - therapeutic use | Plasmodium falciparum - drug effects | Chloroquine - analogs & derivatives | Anti-Bacterial Agents - therapeutic use | Malaria, Falciparum - parasitology | Quinine - therapeutic use | Artemisinins - therapeutic use | Mefloquine - therapeutic use | Azithromycin - therapeutic use | Malaria, Falciparum - epidemiology | Plasmodium falciparum - pathogenicity | Ethanolamines - therapeutic use | Quinolines - therapeutic use | Medical research | Microbial sensitivity tests | Patient outcomes | Medicine, Experimental | Dosage and administration | Research | Health aspects | Drugs | Scholarships & fellowships | Malaria | Erythrocytes | Parasites | Mutation | Index Medicus | field isolates | in vitro culture | antimalarials | Original | Antibiotics - antimalarials - field isolates - in vitro culture - Mizoram - Plasmodium falciparum
Journal Article
Journal Article